The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73583816" target="_blank" >RIV/61989592:15110/17:73583816 - isvavai.cz</a>
Alternative codes found
RIV/27283933:_____/17:00005351 RIV/00216208:11110/17:10366891 RIV/00216208:11150/17:10366891 RIV/00179906:_____/17:10366891 and 2 more
Result on the web
<a href="http://dx.doi.org/10.5114/wo.2017.66656" target="_blank" >http://dx.doi.org/10.5114/wo.2017.66656</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5114/wo.2017.66656" target="_blank" >10.5114/wo.2017.66656</a>

Result language
angličtina
Original language name
The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma
Original language description
Aim of the study: The aim was to examine the effects of neoadjuvant chemoradiotherapy on VEGF expression in patients with locally advanced rectal cancer. Materials and methods: A total of 53 patients with locally advanced rectal cancer were retrospectively studied. Neoadjuvant treatment comprised external beam radiation (50.4 Gy/28 fractions) with continuous infusion of 5-fluorouracil. Four to 6 weeks after the chemoradiotherapy, the patients underwent surgical resection. Immunohistochemistry was performed to assess VEGF expression in the pretreatment biopsies and in resected specimens.
Czech name
—
Czech description
—

Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30204 - Oncology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)